NEUROENDOCRINE NEOPLASM
Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug shows potential to stall neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) better than a placebo. About 298 adults whose cancer worsened after previous treatments will receive either cabozantinib or a dummy pill. The goal is …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Major trial tests two drug cocktails for Hard-to-Treat carcinoid cancer
Disease control OngoingThis study compares two drug combinations for people with advanced neuroendocrine tumors (carcinoid cancer) that cannot be removed by surgery. Participants receive either octreotide plus interferon or octreotide plus bevacizumab. The goal is to see which combination better delays…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New combo therapy shows promise for hard-to-treat liver tumors
Disease control OngoingThis study tests whether adding an immunotherapy drug (pembrolizumab) to either liver-directed treatments or targeted radiation therapy can help shrink neuroendocrine tumors that have spread to the liver. About 32 adults with well-differentiated neuroendocrine tumors and progress…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug combo shows promise for rare gut tumors
Disease control OngoingThis study tests two drugs, lenvatinib and everolimus, given together to people with advanced carcinoid tumors that cannot be removed by surgery. The goal is to see if the combination can shrink tumors or slow their growth. 36 adults with measurable disease are taking part. This …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Scientists test Two-Pronged attack on rare gut tumors
Disease control OngoingThis early-stage trial is testing a new combination treatment for advanced neuroendocrine tumors that have spread in the digestive system. Researchers are combining an oral pill (peposertib) with a targeted radiation therapy (Lutetium-177 dotatate) to see if they work better toge…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 16, 2026 12:47 UTC
-
New PET tracer could reveal hidden cancers
Knowledge-focused OngoingThis early-phase study tests a new imaging agent called 68Ga-FAPI-46, which targets cells around tumors. About 26 adults with various cancers will receive the tracer and then have a PET/CT scan. The goal is to see where the tracer goes in the body and compare it to standard imagi…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 04:34 UTC